TTNP icon

Titan Pharmaceuticals
TTNP

Overview Fund Activity

21 hedge funds and large institutions have $1.14M invested in Titan Pharmaceuticals in 2022 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 3 increasing their positions, 5 reducing their positions, and 7 closing their positions.

Holders
21
Holders Change
-3
Holders Change %
-12.5%
% of All Funds
0.36%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
3
Reduced
5
Closed
7
Calls
$45K
Puts
–
Net Calls
+$45K
Net Calls Change
+$39K

Top Buyers

1
Truist Financial
1
Truist Financial
North Carolina
$675K
2
State Street
2
State Street
Massachusetts
$41K
3
FIA
3
FNY Investment Advisers
New York
$30K
4
Citadel Advisors
4
Citadel Advisors
Florida
$14K
5
Vanguard Group
5
Vanguard Group
Pennsylvania
$88K

Top Sellers

1
Renaissance Technologies
1
Renaissance Technologies
New York
$156K
2
Millennium Management
2
Millennium Management
New York
$19K
3
VF
3
Virtu Financial
New York
$31K
4
Group One Trading
4
Group One Trading
Illinois
$0
5
HF
5
HRT Financial
New York
$0
Name Market Value Shares Shares
Change 		Shares
Change %
BlackRock
26
BlackRock
New York
$0 60 – –
CFGS
27
Concourse Financial Group Securities
Alabama
– – – –
Osaic Holdings
28
Osaic Holdings
Arizona
$0 14 – –
Bank of America
29
Bank of America
North Carolina
$0 206 – –
Morgan Stanley
30
Morgan Stanley
New York
$0 40 +24 +150%
1
2